Csenge Advisory Group’s LivaNova LIVN Stock Holding History

Csenge Advisory Group’s Portfolio LIVN Stock Details LIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11	Closed	-$1K	–	890
2018 Q3	$1K	Buy	+11	New	+$1.3K	﹤0.01%	883

Other funds holding LIVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Csenge Advisory Group's LIVN Position: Q4 2018 in Review

Csenge Advisory Group sold out of LivaNova (LIVN) in Q4 2018, closing a stake of 11 shares — an estimated $1K sold.

Csenge Advisory Group first reported a position in LIVN in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 251 funds tracked by Wall St. Rank hold LIVN as of Q4 2018.

Csenge Advisory Group reported no remaining LivaNova position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 11 LivaNova shares in Q4 2018, an estimated $1K.
Csenge Advisory Group first reported a position in LivaNova in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's LivaNova position peaked at $1K in Q3 2018.
251 funds tracked by Wall St. Rank held LivaNova as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.